Metrics as of 10/13/2026, 06:55 PM (Berlin time), refresh in progress.
FamiCord Stock
FamiCord AG
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Germany
- CEO
- Jakub Julian Baran
- Employees
- 723
- Market cap
- €51 M
- IPO
- 27/03/2007
FamiCord AG is a company operating in the healthcare sector within the biotechnology industry. Headquartered in Leipzig, Germany, the company is led by CEO Jakub Julian Baran. The business model focuses on the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. Its…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
FamiCord stock: price history
1D
+0.0%
1W
-3.0%
1M
+0.3%
6M
-36.3%
YTD
-50.8%
1Y
-51.2%
2Y
-35.3%
5Y
-81.3%
10Y
-40.3%
Next earnings date
Next earnings date
30/11/2026 (in 44 days)
Volatility around earnings
~5% weaker price swings than usual
Ask the agents about FamiCord
FamiCord stock metrics
P/E
-6.8
P/B
10.18
EV/EBITDA
10.98
RETURN ON EQUITY
-22.1%
NET MARGIN
-5.1%
DEBT/EQUITY
4.56
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
31.6%
FLOAT SHARES
5,500,294
AVG. DAILY VOLUME (30D)
777
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about FamiCord stock
What does FamiCord do?
FamiCord AG is a company in the Healthcare sector, Biotechnology industry, headquartered in Germany.
The CEO is Jakub Julian Baran, the company employs around 723 people.
The IPO was on 27/03/2007; the stock trades on XETRA under the ticker V3V.DE.
When does FamiCord report next?
The next earnings date is 30/11/2026.
Around past earnings, price swings were roughly -5% stronger than usual.
Does FamiCord pay a dividend?
Yes. The last dividend was €0.16 per share, ex-date 05/06/2019, paid on 07/06/2019.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to FamiCord?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get FamiCord stock analyzed?
Clicking "Analyze stock" lets five strategies assess FamiCord against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.